trending Market Intelligence /marketintelligence/en/news-insights/trending/xrvxb_hvpiegoy_8w76bta2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

US FTC conditionally approves Abbott's $25B acquisition of St. Jude Medical

MI Mobile App

Independent Networks Gain Little Traction On Virtual Multichannel Services

Big Strategy Decisions Ahead For Viacom As It Moves Into The CBS Fold

Street Talk Episode 48 - Bank M&A, Investing Against An Inverted Yield Curve Overview


US FTC conditionally approves Abbott's $25B acquisition of St. Jude Medical

The U.S. Federal Trade Commission conditionally approved Abbott Laboratories' proposed acquisition of fellow competitor St. Jude Medical Inc. in a deal valued at $25 billion.

Abbott is required to sell its steerable sheath business to Terumo Corp., while St. Jude will off-load its vascular closure device business to the Tokyo-based medical device maker to appease the regulator's anti-competitive concerns.

The companies agreed in principle to sell the businesses to Terumo for $1.12 billion in October.

Vascular closure devices are used to close holes made in an artery and prevent bleeding. Steerable sheaths are used to help position catheters into the heart.